What did @dr.massimo.spattini actually say?
Honestly? It's nearly impossible to tell. The transcript provided for this video is largely incoherent, reading like a garbled auto-transcription of what appears to be a lecture delivered in Italian or a mix of Italian and English. Phrases like "the protein is added protocol, it will shoot the leaves" and extended passages about political candidates and the U.S. government bear no recognizable connection to hormone replacement therapy science.
The caption promises a discussion of "recent scientific research that challenges previous misconceptions about estrogen, progestin, and testosterone treatments." That framing, debunking myths around HRT, is a legitimate and important topic in endocrinology. But based on the available transcript, no specific claims about hormones, dosing, risks, or benefits can be reliably extracted or attributed to the creator. What we can fact-check is the broader territory the video claims to occupy.
Does the science back this up?
The general premise, that earlier HRT research was flawed and that modern data paints a more nuanced picture, is well-supported. The Women's Health Initiative (WHI) study, published in JAMA in 2002, was widely misread as proving HRT caused breast cancer and heart disease across all women. That reading was wrong, or at least badly oversimplified.
Subsequent re-analysis, including work by Manson et al. (2013, JAMA Internal Medicine) and the Danish Osteoporosis Prevention Study (Schierbeck et al., 2012, BMJ), showed that timing matters significantly. Women who began hormone therapy within 10 years of menopause or before age 60 had meaningfully different cardiovascular outcomes than older women who started later. The "timing hypothesis" is now a mainstream position among menopause specialists, not a fringe reinterpretation. If the video is making this argument, the science does support it. The problem is we cannot confirm that's what was said.
What did they get wrong (or right)?
We cannot fairly say the creator got specific claims wrong when the transcript is this degraded. What we can say is that the framing in the caption is accurate as a general position: HRT has been over-stigmatized based on a misreading of older research, and the risks and benefits differ substantially depending on hormone type, formulation, route of administration, patient age, and timing of initiation.
Where creators in this space most commonly go wrong is in overstating testosterone's benefits for women without adequate discussion of the evidence base, which remains thinner than for estrogen therapy. The Global Consensus Position Statement on testosterone therapy in women (Wierman et al., 2019, Journal of Clinical Endocrinology and Metabolism) supports testosterone use for hypoactive sexual desire disorder but explicitly notes insufficient evidence for most other claimed benefits, including cognitive effects and general well-being. Claims that go beyond that boundary should be treated skeptically.
What should you actually know?
HRT is not a monolith. The risks and benefits of estrogen-only therapy differ from combined estrogen-progestogen therapy. Synthetic progestins, particularly medroxyprogesterone acetate used in the original WHI, have different biological effects than micronized progesterone, a distinction supported by the E3N cohort study (Fournier et al., 2008, Breast Cancer Research and Treatment).
For testosterone specifically, the evidence in women supports one indication with reasonable confidence: low libido. Evidence for other outcomes, including body composition, mood, and cognitive function, is preliminary and should not be presented as settled. In men with confirmed hypogonadism, testosterone replacement has a clearer evidence base, though cardiovascular risk in older men with pre-existing disease remains an active area of study (Lincoff et al., 2023, New England Journal of Medicine).
If you are considering any form of hormone therapy, a conversation with a physician who can review your full medical history, baseline labs, and risk factors is the starting point. Social media videos, even from credentialed creators, are not a substitute for individualized clinical evaluation.